Screening for obstructive sleep apnea in adults us preventive services task force recommendation statement

Kirsten Bibbins-Domingo, David C. Grossman, Susan J. Curry, Karina W. Davidson, John W. Epling, Francisco A Garcia, Jessica Herzstein, Alex R. Kemper, Alex H. Krist, Ann E. Kurth, C. Seth Landefeld, Carol M. Mangione, William R. Phillips, Maureen G. Phipps, Michael P. Pignone, Michael Silverstein, Chien Wen Tseng

Research output: Contribution to journalReview article

59 Citations (Scopus)

Abstract

IMPORTANCE Based on data from the 1990s, estimated prevalence of obstructive sleep apnea (OSA) in the United States is 10% for mild OSA and 3.8% to 6.5%for moderate to severe OSA; current prevalence may be higher, given the increasing prevalence of obesity. Severe OSA is associated with increased all-cause mortality, cardiovascular disease and cerebrovascular events, diabetes, cognitive impairment, decreased quality of life, and motor vehicle crashes. OBJECTIVE To issue a new US Preventive Services Task Force (USPSTF) recommendation on screening for OSA in asymptomatic adults. EVIDENCE REVIEW The USPSTF reviewed the evidence on the accuracy, benefits, and potential harms of screening for OSA in asymptomatic adults seen in primary care, including those with unrecognized symptoms. The USPSTF also evaluated the evidence on the benefits and harms of treatment of OSA on intermediate and final health outcomes. FINDINGS The USPSTF found insufficient evidence on screening for or treatment of OSA in asymptomatic adults or adults with unrecognized symptoms. Therefore, the USPSTF was unable to determine the magnitude of the benefits or harms of screening for OSA or whether there is a net benefit or harm to screening. CONCLUSIONS AND RECOMMENDATION The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for OSA in asymptomatic adults. (I statement).

Original languageEnglish (US)
Pages (from-to)407-414
Number of pages8
JournalJAMA - Journal of the American Medical Association
Volume317
Issue number4
DOIs
StatePublished - Jan 24 2017

Fingerprint

Obstructive Sleep Apnea
Advisory Committees
Motor Vehicles
Primary Health Care
Cardiovascular Diseases
Obesity
Quality of Life
Mortality
Health

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Screening for obstructive sleep apnea in adults us preventive services task force recommendation statement. / Bibbins-Domingo, Kirsten; Grossman, David C.; Curry, Susan J.; Davidson, Karina W.; Epling, John W.; Garcia, Francisco A; Herzstein, Jessica; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Landefeld, C. Seth; Mangione, Carol M.; Phillips, William R.; Phipps, Maureen G.; Pignone, Michael P.; Silverstein, Michael; Tseng, Chien Wen.

In: JAMA - Journal of the American Medical Association, Vol. 317, No. 4, 24.01.2017, p. 407-414.

Research output: Contribution to journalReview article

Bibbins-Domingo, K, Grossman, DC, Curry, SJ, Davidson, KW, Epling, JW, Garcia, FA, Herzstein, J, Kemper, AR, Krist, AH, Kurth, AE, Landefeld, CS, Mangione, CM, Phillips, WR, Phipps, MG, Pignone, MP, Silverstein, M & Tseng, CW 2017, 'Screening for obstructive sleep apnea in adults us preventive services task force recommendation statement', JAMA - Journal of the American Medical Association, vol. 317, no. 4, pp. 407-414. https://doi.org/10.1001/jama.2016.20325
Bibbins-Domingo, Kirsten ; Grossman, David C. ; Curry, Susan J. ; Davidson, Karina W. ; Epling, John W. ; Garcia, Francisco A ; Herzstein, Jessica ; Kemper, Alex R. ; Krist, Alex H. ; Kurth, Ann E. ; Landefeld, C. Seth ; Mangione, Carol M. ; Phillips, William R. ; Phipps, Maureen G. ; Pignone, Michael P. ; Silverstein, Michael ; Tseng, Chien Wen. / Screening for obstructive sleep apnea in adults us preventive services task force recommendation statement. In: JAMA - Journal of the American Medical Association. 2017 ; Vol. 317, No. 4. pp. 407-414.
@article{fb91fce1f66f47ad8aa5d3191110b6f6,
title = "Screening for obstructive sleep apnea in adults us preventive services task force recommendation statement",
abstract = "IMPORTANCE Based on data from the 1990s, estimated prevalence of obstructive sleep apnea (OSA) in the United States is 10{\%} for mild OSA and 3.8{\%} to 6.5{\%}for moderate to severe OSA; current prevalence may be higher, given the increasing prevalence of obesity. Severe OSA is associated with increased all-cause mortality, cardiovascular disease and cerebrovascular events, diabetes, cognitive impairment, decreased quality of life, and motor vehicle crashes. OBJECTIVE To issue a new US Preventive Services Task Force (USPSTF) recommendation on screening for OSA in asymptomatic adults. EVIDENCE REVIEW The USPSTF reviewed the evidence on the accuracy, benefits, and potential harms of screening for OSA in asymptomatic adults seen in primary care, including those with unrecognized symptoms. The USPSTF also evaluated the evidence on the benefits and harms of treatment of OSA on intermediate and final health outcomes. FINDINGS The USPSTF found insufficient evidence on screening for or treatment of OSA in asymptomatic adults or adults with unrecognized symptoms. Therefore, the USPSTF was unable to determine the magnitude of the benefits or harms of screening for OSA or whether there is a net benefit or harm to screening. CONCLUSIONS AND RECOMMENDATION The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for OSA in asymptomatic adults. (I statement).",
author = "Kirsten Bibbins-Domingo and Grossman, {David C.} and Curry, {Susan J.} and Davidson, {Karina W.} and Epling, {John W.} and Garcia, {Francisco A} and Jessica Herzstein and Kemper, {Alex R.} and Krist, {Alex H.} and Kurth, {Ann E.} and Landefeld, {C. Seth} and Mangione, {Carol M.} and Phillips, {William R.} and Phipps, {Maureen G.} and Pignone, {Michael P.} and Michael Silverstein and Tseng, {Chien Wen}",
year = "2017",
month = "1",
day = "24",
doi = "10.1001/jama.2016.20325",
language = "English (US)",
volume = "317",
pages = "407--414",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "4",

}

TY - JOUR

T1 - Screening for obstructive sleep apnea in adults us preventive services task force recommendation statement

AU - Bibbins-Domingo, Kirsten

AU - Grossman, David C.

AU - Curry, Susan J.

AU - Davidson, Karina W.

AU - Epling, John W.

AU - Garcia, Francisco A

AU - Herzstein, Jessica

AU - Kemper, Alex R.

AU - Krist, Alex H.

AU - Kurth, Ann E.

AU - Landefeld, C. Seth

AU - Mangione, Carol M.

AU - Phillips, William R.

AU - Phipps, Maureen G.

AU - Pignone, Michael P.

AU - Silverstein, Michael

AU - Tseng, Chien Wen

PY - 2017/1/24

Y1 - 2017/1/24

N2 - IMPORTANCE Based on data from the 1990s, estimated prevalence of obstructive sleep apnea (OSA) in the United States is 10% for mild OSA and 3.8% to 6.5%for moderate to severe OSA; current prevalence may be higher, given the increasing prevalence of obesity. Severe OSA is associated with increased all-cause mortality, cardiovascular disease and cerebrovascular events, diabetes, cognitive impairment, decreased quality of life, and motor vehicle crashes. OBJECTIVE To issue a new US Preventive Services Task Force (USPSTF) recommendation on screening for OSA in asymptomatic adults. EVIDENCE REVIEW The USPSTF reviewed the evidence on the accuracy, benefits, and potential harms of screening for OSA in asymptomatic adults seen in primary care, including those with unrecognized symptoms. The USPSTF also evaluated the evidence on the benefits and harms of treatment of OSA on intermediate and final health outcomes. FINDINGS The USPSTF found insufficient evidence on screening for or treatment of OSA in asymptomatic adults or adults with unrecognized symptoms. Therefore, the USPSTF was unable to determine the magnitude of the benefits or harms of screening for OSA or whether there is a net benefit or harm to screening. CONCLUSIONS AND RECOMMENDATION The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for OSA in asymptomatic adults. (I statement).

AB - IMPORTANCE Based on data from the 1990s, estimated prevalence of obstructive sleep apnea (OSA) in the United States is 10% for mild OSA and 3.8% to 6.5%for moderate to severe OSA; current prevalence may be higher, given the increasing prevalence of obesity. Severe OSA is associated with increased all-cause mortality, cardiovascular disease and cerebrovascular events, diabetes, cognitive impairment, decreased quality of life, and motor vehicle crashes. OBJECTIVE To issue a new US Preventive Services Task Force (USPSTF) recommendation on screening for OSA in asymptomatic adults. EVIDENCE REVIEW The USPSTF reviewed the evidence on the accuracy, benefits, and potential harms of screening for OSA in asymptomatic adults seen in primary care, including those with unrecognized symptoms. The USPSTF also evaluated the evidence on the benefits and harms of treatment of OSA on intermediate and final health outcomes. FINDINGS The USPSTF found insufficient evidence on screening for or treatment of OSA in asymptomatic adults or adults with unrecognized symptoms. Therefore, the USPSTF was unable to determine the magnitude of the benefits or harms of screening for OSA or whether there is a net benefit or harm to screening. CONCLUSIONS AND RECOMMENDATION The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for OSA in asymptomatic adults. (I statement).

UR - http://www.scopus.com/inward/record.url?scp=85011888058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011888058&partnerID=8YFLogxK

U2 - 10.1001/jama.2016.20325

DO - 10.1001/jama.2016.20325

M3 - Review article

C2 - 28118461

AN - SCOPUS:85011888058

VL - 317

SP - 407

EP - 414

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 4

ER -